StepStone Group LP Reports New 6.6% Passive Stake in OnKure Therapeutics, Inc. (OKUR)

On April 7, 2026, StepStone Group LP and its affiliates filed a Schedule 13G reporting a new 6.6% ownership stake in OnKure Therapeutics, Inc. (OKUR). The reporting persons, which include StepStone Master G, L.P. and StepStone VC MI-G GP, LLC, collectively hold 2,660,612 shares of Class A Common Stock. According to the filing, the shares were acquired for investment purposes and not with the intent to influence or change the control of the issuer. StepStone VC MI-G GP, LLC serves as the general partner of Master G, while StepStone Group LP acts as the investment manager for both entities. The ownership percentage is calculated based on 40,395,478 shares of Common Stock outstanding as of April 1, 2026. This filing represents a significant new position for StepStone Group in the biopharmaceutical company, which is headquartered in Boulder, Colorado.